Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-07-18

Clinical Trial Update: The Effects of Inhaled Glucocorticoids on the Postmenopausal Skeleton [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating the effects of inhaled glucocorticoids on the postmenopausal skeleton for osteoporosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inhaled glucocorticoids

Snippet

Sponsor: Columbia University | Conditions: Osteoporosis | Phase 4 | Status: WITHDRAWN